دورية أكاديمية

Correction to: NSABP FB-7: a phase II randomized neoadjuvant trial with paclitaxel + trastuzumab and/or neratinib followed by chemotherapy and postoperative trastuzumab in HER2+ breast cancer

التفاصيل البيبلوغرافية
العنوان: Correction to: NSABP FB-7: a phase II randomized neoadjuvant trial with paclitaxel + trastuzumab and/or neratinib followed by chemotherapy and postoperative trastuzumab in HER2+ breast cancer
المؤلفون: Samuel A. Jacobs, André Robidoux, Jame Abraham, José Manuel Pérez-Garcia, Nicla La Verde, James M. Orcutt, Marina E. Cazzaniga, Fanny Piette, Silvia Antolín, Elena Aguirre, Javier Cortes, Antonio Llombart-Cussac, Serena Di Cosimo, Rim S. Kim, Huichen Feng, Corey Lipchik, Peter C. Lucas, Ashok Srinivasan, Ying Wang, Nan Song, Patrick G. Gavin, April D. Balousek, Soonmyung Paik, Carmen J. Allegra, Norman Wolmark, Katherine L. Pogue-Geile
المصدر: Breast Cancer Research, Vol 22, Iss 1, Pp 1-2 (2020)
بيانات النشر: BMC, 2020.
سنة النشر: 2020
المجموعة: LCC:Neoplasms. Tumors. Oncology. Including cancer and carcinogens
مصطلحات موضوعية: Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
الوصف: After the publication of this work [1] the authors have reported that in Table 3 The letter “T” in columns 5 and 7 should not be there.
نوع الوثيقة: article
وصف الملف: electronic resource
اللغة: English
تدمد: 1465-542X
Relation: https://doaj.org/toc/1465-542X
DOI: 10.1186/s13058-019-1240-y
URL الوصول: https://doaj.org/article/1224ca9686ff4ace8904fdb0d7ec7ea5
رقم الأكسشن: edsdoj.1224ca9686ff4ace8904fdb0d7ec7ea5
قاعدة البيانات: Directory of Open Access Journals
الوصف
تدمد:1465542X
DOI:10.1186/s13058-019-1240-y